SG Capital Management’s Medifast MED Stock Holding History

SG Capital Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-11,249	Closed	-$364K	–	76
2015 Q2	$364K	Buy	+11,249	New	+$357K	0.09%	54

Other funds holding MED

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

SG Capital Management's MED Position: Q3 2015 in Review

SG Capital Management sold out of Medifast (MED) in Q3 2015, closing a stake of 11,249 shares — an estimated $364K sold.

SG Capital Management first reported a position in MED in Q2 2015 and held it in 1 quarter. The position peaked at $364K in Q2 2015. 125 funds tracked by Wall St. Rank hold MED as of Q3 2015.

SG Capital Management reported no remaining Medifast position as of Q3 2015 after selling out during the quarter.
SG Capital Management sold 11,249 Medifast shares in Q3 2015, an estimated $364K.
SG Capital Management first reported a position in Medifast in Q2 2015 and held it in 1 quarter.
SG Capital Management's Medifast position peaked at $364K in Q2 2015.
125 funds tracked by Wall St. Rank held Medifast as of Q3 2015.

Based on SG Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.